The global Venous Thromboembolism (VTE) Treatment Market is on track for steady growth, projected to increase from USD 1,760.42 million in 2024 to USD 2,580.90 million by 2034. This growth corresponds to a compound annual growth rate (CAGR) of 3.9% over the forecast period, reflecting advancements in treatment options and increasing awareness of this life-threatening condition.
Venous thromboembolism, which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), poses significant risks to global health. The rising prevalence of VTE, driven by factors such as aging populations, sedentary lifestyles, and post-operative complications, is fueling the demand for advanced therapeutic solutions. The development of direct oral anticoagulants (DOACs) and improved diagnostic protocols are enhancing patient outcomes and supporting market growth.
North America leads the market, backed by a strong healthcare infrastructure and extensive research on thrombosis management. Europe follows closely, with robust adoption of innovative therapies. Meanwhile, the Asia-Pacific region is emerging as a promising market due to increasing healthcare investments, improved diagnostic capabilities, and growing awareness of VTE prevention and treatment.
As healthcare systems worldwide continue to prioritize effective management of thromboembolic conditions, the VTE treatment market is poised for sustained growth. Stakeholders are focusing on innovative drug development, improved accessibility, and personalized medicine approaches to address the evolving needs of patients.
Key Takeaways:
- The venous thromboembolism treatment market is projected to grow from USD 1,760.42 million in 2024 to USD 2,580.90 million by 2034, at a CAGR of 3.9%.
- Increasing prevalence of VTE and advancements in direct oral anticoagulants (DOACs) are key growth drivers.
- North America leads the market, while Asia-Pacific shows strong potential due to growing healthcare investments.
- Emphasis on personalized medicine and innovation will continue to shape the market landscape.
Competitive Landscape of the Thromboembolism Treatment Market
The demand for the treatment of venous thromboembolism continues to grow, leading companies and manufacturers such as Argon Medical Devices to focus on developing and improving inferior vena cava (IVC) filters. These filters prevent patients from experiencing pulmonary embolism and other VTE complications. These companies are investing heavily in research and development to create new filter designs that prioritize safety, efficacy, and ease of retrieval.
Manufacturers are also expanding their global presence by forming partnerships, collaborations, and distribution networks to ensure their products are widely available and meet the growing demand for VTE treatments worldwide. These initiatives are expected to drive significant growth and improve patient outcomes while globally reducing the burden of VTE-related morbidity and mortality.
Recent Developments:
- Thrombectomy use increased to treat VTE, reported research at the RSNA meeting on November 30, 2023. Over the past five years, arterial and venous thrombectomy saw significant utilization growth, marking a notable trend in addressing blood clots.
- In July 2021, Prof. Jeffrey Weitz reported that a study found abelacimab, a new VTE treatment, reduced VTE rates by 80% compared to enoxaparin after total knee arthroplasty. Weitz stated it’s an attractive therapy due to its effectiveness and reduced risk of bleeding.
- At the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting, held from September 10-14 in Barcelona, Spain, Gerd Grözinger and Bernhard Gebauer discussed challenges in treating pulmonary embolism (PE) and deep vein thrombosis (DVT). Gebauer highlighted limited options with anticoagulation or lysis.
Full Report Revealed
Key Companies in the Market
- Stryker Corporation
- Argon Medical Devices
- Cardinal Health (Medtronic)
- Cook Medical
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Arjo
- DJO Global
Market Segmentation
By Product:
- Non-Segmented Pneumatic Compression Pumps
- Segmented Pneumatic Compression Pumps without Gradient
- Segmented Pneumatic Compression Pumps with Calibrated Gradient
- Upper Pneumatic Compression Sleeves
- Lower Pneumatic Compression Sleeves
- Permanent Inferior Vena Cava Filters
- Retrievable Inferior Vena Cava Filters
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis (CDT) Devices
By Disease Indication:
- Deep Venous Thrombosis
- Pulmonary Embolism
By End User:
- Hospitals
- Catheterisation Laboratories
- Ambulatory Surgical Centres
By Region:
- Asia Pacific
- Europe
- North America
- Middle East & Africa
- Latin America
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube